232 related articles for article (PubMed ID: 35833112)
1. Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review.
Tonutti A; Motta F; Ceribelli A; Isailovic N; Selmi C; De Santis M
Front Immunol; 2022; 13():937667. PubMed ID: 35833112
[TBL] [Abstract][Full Text] [Related]
2. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C).
David P; Sinha S; Iqbal K; De Marco G; Taheri S; McLaren E; Maisuria S; Arumugakani G; Ash Z; Buckley C; Coles L; Hettiarachchi C; Payne E; Savic S; Smithson G; Slade M; Shah R; Marzo-Ortega H; Keen M; Lawson C; Mclorinan J; Nizam S; Reddy H; Sharif O; Sultan S; Tran G; Wood M; Wood S; Ghosh P; McGonagle D
EBioMedicine; 2024 Jun; 104():105136. PubMed ID: 38723554
[TBL] [Abstract][Full Text] [Related]
3. MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C).
Iqbal K; Sinha S; David P; De Marco G; Taheri S; McLaren E; Maisuria S; Arumugakani G; Ash Z; Buckley C; Coles L; Hettiarachchi C; Smithson G; Slade M; Shah R; Marzo-Ortega H; Keen M; Lawson C; Mclorinan J; Nizam S; Reddy H; Sharif O; Sultan S; Tran G; Wood M; Wood S; Ghosh P; McGonagle D
medRxiv; 2023 Nov; ():. PubMed ID: 37961408
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination.
Zhang X; Yang Z; Pan T; Sun Q; Chen Q; Wang PH; Li X; Kuang E
PLoS Pathog; 2023 Nov; 19(11):e1011792. PubMed ID: 37956198
[TBL] [Abstract][Full Text] [Related]
5. Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.
Gonzalez D; Gupta L; Murthy V; Gonzalez EB; Williamson KA; Makol A; Tan CL; Sulaiman FN; Shahril NS; Isa LM; Martín-Nares E; Aggarwal R
Rheumatol Int; 2022 Sep; 42(9):1629-1641. PubMed ID: 35661906
[TBL] [Abstract][Full Text] [Related]
6. The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients.
Ono N; Kai K; Maruyama A; Sakai M; Sadanaga Y; Koarada S; Inoue T; Tada Y
Rheumatology (Oxford); 2019 May; 58(5):786-791. PubMed ID: 30541137
[TBL] [Abstract][Full Text] [Related]
7. The RNA sensor MDA5 detects SARS-CoV-2 infection.
Sampaio NG; Chauveau L; Hertzog J; Bridgeman A; Fowler G; Moonen JP; Dupont M; Russell RA; Noerenberg M; Rehwinkel J
Sci Rep; 2021 Jul; 11(1):13638. PubMed ID: 34211037
[TBL] [Abstract][Full Text] [Related]
8. Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection.
Sun X; Quan L; Chen R; Liu D
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232993
[TBL] [Abstract][Full Text] [Related]
9. Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study.
Wang G; Wang Q; Wang Y; Liu C; Wang L; Chen H; Jiao T; Hu C; Lei X; Guo L; Ren L; Li M; Zhao Y; Zeng X; Zhang D; Cao B; Wang J
Front Immunol; 2021; 12():791348. PubMed ID: 34987516
[TBL] [Abstract][Full Text] [Related]
10. The intersection molecule MDA5 in Cancer and COVID-19.
Jin R; Cao X; Lu M; Gao Q; Ma T
Front Immunol; 2022; 13():963051. PubMed ID: 36119095
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report.
Anderle K; Machold K; Kiener HP; Bormann D; Hoetzenecker K; Geleff S; Prosch H; Laccone F; Heil PM; Petzelbauer P; Aletaha D; Blüml S; Kastrati K
BMC Rheumatol; 2022 Jul; 6(1):42. PubMed ID: 35821079
[TBL] [Abstract][Full Text] [Related]
12. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.
Crampton SP; Deane JA; Feigenbaum L; Bolland S
J Immunol; 2012 Feb; 188(3):1451-9. PubMed ID: 22205024
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
Kondo Y; Kaneko Y; Takei H; Tamai H; Kabata H; Suhara T; Yamamoto R; Nagata H; Ishii M; Sasaki J; Hasegawa N; Fukunaga K; Takeuchi T;
Clin Exp Rheumatol; 2021; 39(3):631-638. PubMed ID: 33886458
[TBL] [Abstract][Full Text] [Related]
14. DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70.
Takashima K; Oshiumi H; Matsumoto M; Seya T
J Innate Immun; 2018; 10(1):44-55. PubMed ID: 29069650
[TBL] [Abstract][Full Text] [Related]
15. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
16. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
17. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.
Melki I; Devilliers H; Gitiaux C; Bondet V; Duffy D; Charuel JL; Miyara M; Bokov P; Kheniche A; Kwon T; Authier FJ; Allenbach Y; Belot A; Bodemer C; Bourrat E; Dumaine C; Fabien N; Faye A; Frémond ML; Hadchouel A; Kitabayashi N; Lepelley A; Martin-Niclos MJ; Mudumba S; Musset L; Quartier P; Rice GI; Seabra L; Uettwiller F; Uggenti C; Viel S; Rodero MP; Crow YJ; Bader-Meunier B
Rheumatology (Oxford); 2020 Aug; 59(8):1927-1937. PubMed ID: 31755959
[TBL] [Abstract][Full Text] [Related]
18. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5.
Funabiki M; Kato H; Miyachi Y; Toki H; Motegi H; Inoue M; Minowa O; Yoshida A; Deguchi K; Sato H; Ito S; Shiroishi T; Takeyasu K; Noda T; Fujita T
Immunity; 2014 Feb; 40(2):199-212. PubMed ID: 24530055
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent effect of the IFIH1/MDA5 gene variants on the risk of critical COVID-19.
Muñiz-Banciella MG; Albaiceta GM; Amado-Rodríguez L; Del Riego ES; Alonso IL; López-Martínez C; Martín-Vicente P; García-Clemente M; Hermida-Valverde T; Enríquez-Rodriguez AI; Hernández-González C; Cuesta-Llavona E; Alvarez V; Gómez J; Coto E
Immunogenetics; 2023 Apr; 75(2):91-98. PubMed ID: 36434151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
